CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
Taku Yoshida(Sapporo Medical University), Kornélia Polyák(Dana-Farber Cancer Institute), Jun Yao(The University of Texas MD Anderson Cancer Center), Stanislawa Weremowicz(Brigham and Women's Hospital), Ying Su(Sanford Burnham Prebys Medical Discovery Institute), Henry W. Long(Dana-Farber Cancer Institute), Laura Mulvey(Dana-Farber Cancer Institute), Kristopher Carver(University of Wisconsin–Madison), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Jee Hyun Kim(Korea University), Shenglin Mei(Air Force Medical University)
Cited by 109
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k